Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Anders

Showing results (131-140 of 271) with videos related to

Pageof 28
Sort By:
Frontiers in Oncology|April 20, 2017
Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome PatientDonna M Cartledge, Katherine M Robbins, Katherine M Drake, et al.
JAMIA Open|November 20, 2020
Implementation of a learning healthcare system for sickle cell diseaseRobin Miller, Erin Coyne, Erin L Crowgey, et al.
Pediatric Blood & Cancer|March 3, 2015
A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium reportE Anders Kolb, Valerie Sampson, Deborah Stabley, et al.
Pediatric Blood & Cancer|January 25, 2020
Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium reportE Anders Kolb, Peter J Houghton, Raushan T Kurmasheva, et al.
Pediatric Blood & Cancer|June 29, 2010
Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing programChristopher L Morton, Peter J Houghton, E Anders Kolb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2020
Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology GroupTodd M Cooper, Michael J Absalon, Todd A Alonzo, et al.
Pediatric Blood & Cancer|February 19, 2010
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing ProgramPeter J Houghton, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|December 19, 2007
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing programRichard Lock, Hernan Carol, Peter J Houghton, et al.
Pediatric Blood & Cancer|July 23, 2019
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working GroupUma Athale, Nobuko Hijiya, Briana C Patterson, et al.
Pediatric Blood & Cancer|October 17, 2022
Evaluation of the pan-class I phosphoinositide 3-kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcomaDouglas Harrison, Jonathan Gill, Michael Roth, et al.
Pageof 28

Showing results (131-140 of 271) with videos related to

Sort By:
Pageof 28
Frontiers in Oncology|April 20, 2017
Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome PatientDonna M Cartledge, Katherine M Robbins, Katherine M Drake, et al.
JAMIA Open|November 20, 2020
Implementation of a learning healthcare system for sickle cell diseaseRobin Miller, Erin Coyne, Erin L Crowgey, et al.
Pediatric Blood & Cancer|March 3, 2015
A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium reportE Anders Kolb, Valerie Sampson, Deborah Stabley, et al.
Pediatric Blood & Cancer|January 25, 2020
Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium reportE Anders Kolb, Peter J Houghton, Raushan T Kurmasheva, et al.
Pediatric Blood & Cancer|June 29, 2010
Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing programChristopher L Morton, Peter J Houghton, E Anders Kolb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2020
Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology GroupTodd M Cooper, Michael J Absalon, Todd A Alonzo, et al.
Pediatric Blood & Cancer|February 19, 2010
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing ProgramPeter J Houghton, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|December 19, 2007
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing programRichard Lock, Hernan Carol, Peter J Houghton, et al.
Pediatric Blood & Cancer|July 23, 2019
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working GroupUma Athale, Nobuko Hijiya, Briana C Patterson, et al.
Pediatric Blood & Cancer|October 17, 2022
Evaluation of the pan-class I phosphoinositide 3-kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcomaDouglas Harrison, Jonathan Gill, Michael Roth, et al.
Pageof 28